Projected Income Statement: Valbiotis

Forecast Balance Sheet: Valbiotis

Forecast Balance Sheet - Valbiotis
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -14.2 -13.7 -18.1 -5.86 -3.59 6.2 14.5 21.2
Change - 3.52% -32.12% 67.62% 38.74% 272.89% 133.87% 46.21%
Announcement Date 3/15/22 3/15/23 4/26/24 3/3/25 3/2/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Valbiotis

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 0.306 0.111 0.027 0.147 0.151 0.1 0.1 0.1
Change - -63.73% -75.68% 444.44% 2.72% -33.77% 0% 0%
Free Cash Flow (FCF) 1 -7.462 -9.303 -8.086 -11.68 -8.189 -8.5 -8.3 -6.7
Change - -24.67% 13.08% -44.5% 29.91% -3.8% 2.35% 19.28%
Announcement Date 3/15/22 3/15/23 4/26/24 3/3/25 3/2/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Valbiotis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

         
EBITDA Margin (%) - -279.76% -397.09% -94.64% -211.8% -879.35% -425% -93.85% -17.2%
EBIT Margin (%) - -314.7% -427.36% -105.45% -224.44% -907.65% -430% -95.38% -17.83%
EBT Margin (%) - - - - - - - - -
Net margin (%) - -322.35% -437.53% -108.21% -215.87% -900.29% -440% -100% -14.65%
FCF margin (%) - -277.09% -330.6% -118.75% -251.59% -782.89% -425% -127.69% -42.68%
FCF / Net Income (%) - 85.96% 75.56% 109.74% 116.55% 86.96% 96.59% 127.69% 291.3%

Profitability

         
ROA -11.78% -21.18% -26.87% -14.79% -24.63% -34.91% - - -
ROE -49.71% -80.95% -89.05% -44.71% -66.9% -108.68% - - -

Financial Health

         
Leverage (Debt/EBITDA) - - - - - - -0.73x -2.38x -7.85x
Debt / Free cash flow - - - - - - -0.73x -1.75x -3.16x

Capital Intensity

         
CAPEX / Current Assets (%) - 11.36% 3.94% 0.4% 3.17% 14.44% 5% 1.54% 0.64%
CAPEX / EBITDA (%) - -4.06% -0.99% -0.42% -1.49% -1.64% -1.18% -1.64% -3.7%
CAPEX / FCF (%) - -4.1% -1.19% -0.33% -1.26% -1.84% -1.18% -1.2% -1.49%

Items per share

         
Cash flow per share 1 - -0.7814 -0.9088 -0.6464 -0.7305 -0.4054 - - -
Change - - -16.3% 28.87% -13.01% 44.5% - - -
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - 1.471 1.077 1.573 - - - - -
Change - - -26.8% 46.09% - - - - -
EPS 1 - -0.94 -1.21 -0.59 -0.63 -0.47 -0.25 -0.18 -0.06
Change - - -28.72% 51.24% -6.78% 25.4% 46.81% 28% 66.67%
Nbr of stocks (in thousands) - 9,717 12,405 12,409 15,763 23,656 35,492 35,492 35,492
Announcement Date - 3/15/22 3/15/23 4/26/24 3/3/25 3/2/26 - - -
1EUR
Estimates
2026 *2027 *
P/E -2.51x -3.49x
PBR - -
EV / Sales 14.2x 5.66x
Yield - -

EPS & Dividend

EPS & Dividend - Valbiotis


Y-o-Y evolution of P/E

Valuation ratios - P/E - Valbiotis
 
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Valbiotis
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.6280EUR
Average target price
1.350EUR
Spread / Average Target
+114.97%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Valbiotis